Showing results (411-420 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|August 20, 2021
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular CarcinomaChia-Lang Hsu, Da-Liang Ou, Li-Yuan Bai, et al.
Liver Cancer|August 20, 2021
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life CohortFabian Finkelmeier, Bernhard Scheiner, Catherine Leyh, et al.
Liver Cancer|August 18, 2022
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)Juxian Sun, Rongping Guo, Xinyu Bi, et al.
Liver Cancer|August 18, 2022
Erratum
Liver Cancer|August 18, 2022
Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic CholangiocarcinomaShoji Kubo, Hiroji Shinkawa, Yoshinari Asaoka, et al.
Liver Cancer|December 24, 2021
Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular CarcinomaKa Shing Cheung, Lok Ka Lam, Wai Kay Seto, et al.
Liver Cancer|December 24, 2021
Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven CriteriaYa-Wen Hung, I-Cheng Lee, Chen-Ta Chi, et al.
Liver Cancer|March 12, 2021
Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment OutcomesDong Ho Lee, Jing Woong Kim, Jeong Min Lee, et al.
Liver Cancer|March 12, 2021
Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in KoreaMyung Ji Goh, Joo Hyun Oh, Yewan Park, et al.
Liver Cancer|March 12, 2021
Feasibility and Techniques of Securing 3D-Safety Margin in Superselective Transarterial Chemoembolization to Improve Local Tumor Control for Small Hepatocellular Carcinoma: An Intend-to-Treat AnalysisChing Charoenvisal, Toshihiro Tanaka, Hideyuki Nishiofuku, et al.
Pageof 55